Jun 29, 2024, 06:38
Ajay Major: Methylphenidate versus piperonyl butoxide RCT for cancer related fatigue
Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and President at Pager Publications, shared a post on X:
“Methylphenidate versus piperonyl butoxide Randomized Controlled Trial (RCT) for cancer-related fatigue Journal of Clinical Oncology:
- 162 patients, all incurable cancer with baseline fatigue.
- nonsignificant Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT-F) fatigue scores.
- no difference in other Quality of Life (QoL) domains.
- Important pallonc trial with pro as primary endpoint.”
Source: Ajay Major/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 23, 2024, 05:24
Oct 23, 2024, 05:17
Oct 23, 2024, 05:11
Oct 23, 2024, 05:05
Oct 23, 2024, 04:41
Oct 23, 2024, 04:34
Oct 23, 2024, 04:16
Oct 23, 2024, 04:04
Oct 23, 2024, 03:50